These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 26862918

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Generation of Stable Influenza Virus Hemagglutinin through Structure-Guided Recombination.
    Tsai CH, Wei SC, Jan JT, Liao LL, Chang CJ, Chao YC.
    ACS Synth Biol; 2019 Nov 15; 8(11):2472-2482. PubMed ID: 31565926
    [Abstract] [Full Text] [Related]

  • 23. Amino Acid Substitutions Improve the Immunogenicity of H7N7HA Protein and Protect Mice against Lethal H7N7 Viral Challenge.
    Kumar SR, Prabakaran M, Ashok Raj KV, He F, Kwang J.
    PLoS One; 2015 Nov 15; 10(6):e0128940. PubMed ID: 26030920
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
    Hervé PL, Lorin V, Jouvion G, Da Costa B, Escriou N.
    Virology; 2015 Dec 15; 486():134-45. PubMed ID: 26433051
    [Abstract] [Full Text] [Related]

  • 27. ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans.
    Chung KY, Coyle EM, Jani D, King LR, Bhardwaj R, Fries L, Smith G, Glenn G, Golding H, Khurana S.
    Vaccine; 2015 Jul 31; 33(32):3953-62. PubMed ID: 26093202
    [Abstract] [Full Text] [Related]

  • 28. Serologic assay for avian-origin influenza A (H7N9) virus in adults of Shanghai, Guangzhou and Yunnan, China.
    Wang W, Peng H, Tao Q, Zhao X, Tang H, Tang Z, Wang Y, Wang Y, Zhao P, Qi Z.
    J Clin Virol; 2014 Jul 31; 60(3):305-8. PubMed ID: 24793969
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Specific Monoclonal Antibodies Targeting Unique HA Epitopes Block H7N9 Influenza A Viral Replication.
    Shen W, Wang Q, Wang Z, Liu M, Du Y, Yuan L, Han L, Smietanka K, Chen H, Xu S, Zhu Q.
    J Virol; 2022 Sep 28; 96(18):e0123822. PubMed ID: 36037479
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Structure-function analysis of neutralizing antibodies to H7N9 influenza from naturally infected humans.
    Huang KA, Rijal P, Jiang H, Wang B, Schimanski L, Dong T, Liu YM, Chang P, Iqbal M, Wang MC, Chen Z, Song R, Huang CC, Yang JH, Qi J, Lin TY, Li A, Powell TJ, Jan JT, Ma C, Gao GF, Shi Y, Townsend AR.
    Nat Microbiol; 2019 Feb 28; 4(2):306-315. PubMed ID: 30478290
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Potency determination of inactivated H7 influenza vaccines using monoclonal antibody-based ELISA and biolayer interferometry assays.
    Vasudevan A, Woerner A, Schmeisser F, Verma S, Williams O, Weir JP.
    Influenza Other Respir Viruses; 2018 Mar 28; 12(2):250-258. PubMed ID: 29152878
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.